Ludivine Breger (Former)
1 – 10 of 11
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Optimization of production and transgene expression of a retrogradely transported pseudotyped lentiviral vector
(
- Contribution to journal › Article
-
Mark
Impact of α-synuclein pathology on transplanted hESC-derived dopaminergic neurons in a humanized α-synuclein rat model of PD
2020) In Proceedings of the National Academy of Sciences of the United States of America 117(26). p.15209-15220(
- Contribution to journal › Article
- 2019
-
Mark
GDNF-mediated rescue of the nigrostriatal system depends on the degree of degeneration
(
- Contribution to journal › Article
- 2018
-
Mark
Destabilizing Domains Enable Long-Term and Inert Regulation of GDNF Expression in the Brain
(
- Contribution to journal › Article
-
Mark
Striatonigral neurons divide into two distinct morphological-physiological phenotypes after chronic L-DOPA treatment in parkinsonian rats
(
- Contribution to journal › Article
- 2017
-
Mark
Modeling Parkinson’s disease pathology by combination of fibril seeds and α-synuclein overexpression in the rat brain
2017) In Proceedings of the National Academy of Sciences of the United States of America 114(39). p.8284-8293(
- Contribution to journal › Article
- 2016
-
Mark
Regulated Gene Therapy.
(
- Contribution to journal › Article
-
Mark
A regulatable AAV vector mediating GDNF biological effects at clinically-approved sub-antimicrobial doxycycline doses
(
- Contribution to journal › Article
- 2013
-
Mark
L-DOPA and graft-induced dyskinesia : different treatment, same story?
(
- Contribution to journal › Article
-
Mark
Comparison of rating scales used to evaluate L-DOPA-induced dyskinesia in the 6-OHDA lesioned rat
(
- Contribution to journal › Article